Literature DB >> 16985829

Choosing earlier therapy for muscle-invasive bladder cancer.

John P Stein.   

Abstract

Entities:  

Year:  2005        PMID： 16985829      PMCID： PMC1477572     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  10 in total

1.  Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression.

Authors:  Sten Holmang; Sonny L Johansson
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

Review 2.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Authors:  J I Epstein; M B Amin; V R Reuter; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

Review 3.  Superficial bladder cancer: the role of molecular markers in the treatment of high-risk superficial disease.

Authors:  S B Malkowicz
Journal:  Semin Urol Oncol       Date:  1997-08

4.  Accurate pathological staging of urothelial neoplasms requires better cystoscopic sampling.

Authors:  Nicholas A Maruniak; Kimiko Takezawa; William M Murphy
Journal:  J Urol       Date:  2002-06       Impact factor: 7.450

5.  Impact of a second transurethral resection on the staging of T1 bladder cancer.

Authors:  Guido Dalbagni; Harry W Herr; Victor E Reuter
Journal:  Urology       Date:  2002-11       Impact factor: 2.649

6.  The value of a second transurethral resection in evaluating patients with bladder tumors.

Authors:  H W Herr
Journal:  J Urol       Date:  1999-07       Impact factor: 7.450

Review 7.  Prognostic markers in bladder cancer: a contemporary review of the literature.

Authors:  J P Stein; G D Grossfeld; D A Ginsberg; D Esrig; J A Freeman; A J Figueroa; D G Skinner; R J Cote
Journal:  J Urol       Date:  1998-09       Impact factor: 7.450

8.  Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer.

Authors:  Y Hasui; Y Osada; S Kitada; S Nishi
Journal:  Urology       Date:  1994-06       Impact factor: 2.649

9.  Bacillus Calmette-Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression.

Authors:  P Andius; S Holmäng
Journal:  BJU Int       Date:  2004-05       Impact factor: 5.588

10.  Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy.

Authors:  Barthold Ph Schrier; Maarten P Hollander; Bas W G van Rhijn; Lambertus A L M Kiemeney; J Alfred Witjes
Journal:  Eur Urol       Date:  2004-03       Impact factor: 20.096
  10 in total
  1 in total

1.  Changes in autofluorescence based organoid model of muscle invasive urinary bladder cancer.

Authors:  Scott Palmer; Karina Litvinova; Andrey Dunaev; Stewart Fleming; David McGloin; Ghulam Nabi
Journal:  Biomed Opt Express       Date:  2016-03-07       Impact factor: 3.732
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.